Sanofi will buy drugmaker Bioverativ for more than $11.5 billion; deal is expected to close within three monthshttp://on.wsj.com/2DXIaaI
0 replies
22 retweets
40 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.